A Novel Double-Tracer Technique to Characterize Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]Tofogliflozin After Oral Administration and Concomitant Intravenous Microdose Administration of [13C]Tofogliflozin in Humans

被引：0
作者：
Dietmar Schwab
Agnes Portron
Zoe Backholer
Berthold Lausecker
Kosuke Kawashima
机构：
[1] F. Hoffmann-La Roche AG,pRED Clinical Pharmacology
[2] F. Hoffmann-La Roche AG,pRED Clinical Operations
[3] F. Hoffmann-La Roche AG,pRED DMPK and Bioanalytical R&D
[4] Chugai Pharmaceutical Co.,Research Division
[5] Ltd.,undefined
来源：
Clinical Pharmacokinetics | 2013年 / 52卷
关键词：
Healthy Male Subject; SGLT2 Inhibitor; Mass Balance Study; Absolute Oral Bioavailability; Proximal Tubulus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：463 / 473
页数：10
相关论文
共 99 条
[1]  
Suzuki M(2012)Tofogliflozin, a potent and highly specific sodium/glucose cotransporter 2 inhibitor, improves glycemic control in diabetic rats and mice J Pharmacol Exp Ther 341 692-701
[2]  
Honda K(2011)Glucose transport by human renal Na Am J Physiol Cell Physiol 300 C14-C21
[3]  
Fukazawa M(2009)/ Kidney Int 75 1272-1277
[4]  
Ozawa K(2008)-glucose cotransporters SGLT1 and SGLT2 Endocr Pract 14 782-790
[5]  
Hagita H(2010)Renal sodium-glucose transport: role in diabetes mellitus and potential clinical implications Nat Rev Drug Discov 9 551-559
[6]  
Kawai T(2008)Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus Expert Opin Drug Metab Toxicol 4 1499-1506
[7]  
Hummel CS(2006)SGLT2 inhibition—a novel strategy for diabetes treatment Clin Pharmacol Ther 80 203-215
[8]  
Lu C(2006)The utility of microdosing over the past 5 years Expert Opin Drug Metab Toxicol 2 419-427
[9]  
Loo DD(2010)Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs Eur J Pharm Sci 40 125-131
[10]  
Hirayama BA(2008)The use of isotopes in the determination of absolute bioavailability of drugs in humans Pharm Res 25 1572-1582
12345678910